# 04_QA_REPORT.md

# Quality Assurance Report

## Identity

| Field | Value |
|---|---|
| QA Report ID | QA-PP-0197 |
| Population Package | PP-0197 |
| Title | Subtotal Gastrectomy |
| Version | 1.0.0 |
| Review Status | PASS |
| Production Status | GOLD |

## Layer 1 — Content QA

| Criterion | Result | QA Note |
|---|---|---|
| Single educational question | PASS | The package answers what subtotal gastrectomy is, when it is used, why it may be chosen, what it entails conceptually, and what patients should expect. |
| Scope respected | PASS | Subtotal gastrectomy is the atomic owner; total gastrectomy, detailed lymphadenectomy, reconstruction technique and systemic therapy remain delegated. |
| Complete coverage | PASS | Definition, selection logic, margins, distal/proximal forms, lymph-node context, reconstruction, approach, risks, nutrition, palliative use and downstream interfaces are covered. |
| Internal consistency | PASS | CKO, KP and Evidence Package use the same clinical question and ownership boundary. |
| Logical organization | PASS | Content follows tumor location → resectability → subtotal operation → oncologic adequacy → reconstruction → recovery → downstream care. |
| Knowledge blocks complete | PASS | Independent patient-facing knowledge blocks cover the major clinical concepts. |
| Common misconceptions addressed | PASS | The package distinguishes subtotal from total, curative from palliative, minimally invasive from automatically superior, and negative margin from cure. |
| Knowledge Graph complete | PASS | Prerequisite, related and downstream packages are defined. |
| Adjacent PP overlap controlled | PASS | PP-0196, PP-0198, PP-0199–0202 and therapy-specific packages have explicit ownership boundaries. |

## Layer 2 — Clinical QA

| Criterion | Result | QA Note |
|---|---|---|
| Scientifically accurate within source-supported scope | PASS | Core claims are grounded in NCCN v2.2026, NCI PDQ and supplied ACS/Vietnamese materials. |
| Consistent with NCCN gastric-cancer guidance | PASS | Adequate resection, negative microscopic margins, regional lymphadenectomy, spleen preservation and selected minimally invasive surgery are represented conservatively. |
| Consistent with NCI treatment framework | PASS | Location-based subtotal selection and subtotal-versus-total comparison are represented with the source's context limitations. |
| Consistent with ACS patient education | PASS | Partial gastrectomy, distal/proximal terminology, reconstruction, approaches, experience, palliative use and nutrition are represented. |
| No unsupported clinical claim | PASS | No universal margin distance, reconstruction technique, or treatment algorithm is invented. |
| No unsafe medical advice | PASS | No individualized surgical recommendation or postoperative prescription is provided. |
| Subtotal versus total appropriately qualified | PASS | The package does not state that subtotal gastrectomy is universally preferable. |
| Margin language appropriately qualified | PASS | Negative microscopic margins are presented as a principle; exact distances are not universalized. |
| Minimally invasive language appropriately qualified | PASS | Approach is described as selected and expertise-dependent. |
| Palliative intent appropriately qualified | PASS | Symptom relief is distinguished from cure. |
| Nutritional consequences appropriately qualified | PASS | Potential deficiencies and dumping are acknowledged without individualized dosing or management. |

## Layer 3 — Educational QA

| Criterion | Result | QA Note |
|---|---|---|
| Plain language | PASS | Medical terms such as subtotal gastrectomy, negative margin, lymphadenectomy and dumping syndrome are explained. |
| Patient-friendly wording | PASS | The operation is explained through practical questions and consequences rather than operative jargon. |
| Learning objectives satisfied | PASS | Each objective maps to a clinical knowledge block. |
| Logical learning progression | PASS | The reader moves from why the operation is considered to what it means and what follows afterward. |
| Common misconceptions addressed | PASS | Dedicated section corrects common overgeneralizations. |
| Practical usefulness | PASS | Patient-facing questions are provided for discussion with the surgical/oncology team. |
| Uncertainty communication | PASS | Context-dependent decisions are clearly labeled. |
| Avoids overpromising | PASS | No cure guarantee, universal superiority, or normal-function guarantee is given. |
| Appropriate referral to clinical team | PASS | Individualized decisions are explicitly left to the treating team. |

## Layer 4 — Governance QA

| Criterion | Result | QA Note |
|---|---|---|
| CKO completed | PASS | 01_CKO.md produced. |
| Knowledge Passport completed | PASS | 02_KNOWLEDGE_PASSPORT.md produced. |
| Evidence Package completed | PASS | 03_PRIMARY_EVIDENCE_PACKAGE.md produced. |
| QA Report completed | PASS | This artifact completed. |
| Gold specification followed | PASS | Four-artifact structure preserved. |
| Approved Decision Batch respected | PASS | PP-0197 locked scope implemented without reopening decisions. |
| Source-first rule respected | PASS | Relevant project Source Files were searched before production. |
| Gold reference depth preserved | PASS | Artifacts were produced as full-depth Gold assets rather than compact summaries. |
| Artifact naming compliant | PASS | Standard artifact names used. |
| Versioning compliant | PASS | Semantic version 1.0.0 used. |
| Knowledge Graph complete | PASS | Prerequisite, related and downstream links included. |
| Boundary ownership preserved | PASS | Core / Supporting / Explicitly Excluded / Delegated-to PP structure preserved. |
| Repository-ready structure | PASS | Four Markdown artifacts packaged in one PP directory and ZIP. |

## Clinical Safety Review

| Safety Item | Result | QA Note |
|---|---|---|
| No individualized surgical recommendation | PASS | The package explains selection principles without telling an individual patient which operation to choose. |
| No individualized treatment sequence | PASS | Perioperative/adjuvant therapy is referenced only as downstream context. |
| No detailed operative instruction | PASS | No incision, vessel ligation, stapling, or anastomotic instructions are provided. |
| No universal margin distance | PASS | The package uses adequate negative microscopic margin language. |
| No universal superiority claim | PASS | Subtotal is not described as always better than total. |
| No false reassurance from negative margin | PASS | Negative margin is presented as an important surgical endpoint, not a guarantee against recurrence. |
| No automatic spleen removal claim | PASS | Routine splenectomy is explicitly rejected as a default. |
| No automatic minimally invasive claim | PASS | Approach depends on selection and expertise. |
| No cure claim for palliative surgery | PASS | Palliative intent is clearly separated from curative intent. |
| No individualized nutritional prescription | PASS | Monitoring concepts are described without doses or schedules. |

## Boundary QA

The four-part ownership boundary is consistent across the four artifacts and adjacent packages.

**Core =** Subtotal gastrectomy as a specific oncologic partial-gastric resection, including selection logic, margins, distal/proximal forms, reconstruction concept, approaches, risks, and nutritional consequences.

**Supporting =** Context such as omentum, spleen preservation, adjacent-organ resection, D1/D2 concepts, pathology, feeding support, perioperative treatment and survivorship.

**Explicitly Excluded =** Detailed operative technique, detailed lymph-node anatomy/procedures, reconstruction technique, exact nutritional treatment, systemic regimens, individualized decisions and detailed surveillance.

**Delegated-to PP =** PP-0196, PP-0198–0207 and dedicated nutrition, reconstruction, complication, surveillance and recurrence packages.

## Evidence Traceability QA

- NCCN v2.2026 supports the resectable-surgery framework, adequate gastric resection, negative microscopic margins, regional lymphadenectomy, spleen preservation and selected minimally invasive approaches.
- NCI PDQ supports location-based subtotal selection and the cited subtotal-versus-total survival/morbidity comparison.
- ACS Stomach Cancer supports patient-facing description of partial gastrectomy, distal/proximal forms, reconstruction, surgical approaches and surgeon experience.
- ACS Chemotherapy for Stomach Cancer supports lymph-node, palliative subtotal gastrectomy and feeding-support context.
- ACS Immunotherapy for Stomach Cancer supports potentially resectable treatment sequencing and surgery after inadequate endoscopic resection.
- The Vietnamese guideline is used as supporting local clinical context and not to silently universalize a single technical rule.

## Artifact Completeness Check

| Artifact | Present | Structural QA |
|---|---|---|
| 01_CKO.md | PASS | Identity, objectives, scope, clinical knowledge blocks, patient explanation, misconceptions, key messages, Knowledge Graph and revision history present |
| 02_KNOWLEDGE_PASSPORT.md | PASS | Identity, classification, runtime use, retrieval, graph, scope, sources, evidence classification, governance and versioning present |
| 03_PRIMARY_EVIDENCE_PACKAGE.md | PASS | Clinical question, scope, source hierarchy, evidence matrix, notes, claims, consistency review, gaps, update triggers, traceability and boundary verification present |
| 04_QA_REPORT.md | PASS | Four QA layers, safety review, boundary QA, traceability, completeness and final decision present |

## Gold Depth Review

The production preserves the project's absolute Gold-depth rule. No artifact has been reduced to a compact summary. Clinical reasoning is distributed across independent knowledge blocks; the Evidence Package includes a claim-level matrix and evidence notes; the QA Report evaluates content, clinical, educational, governance and safety dimensions substantively. The package intentionally maintains the same artifact architecture and depth philosophy used by the approved Gold reference packages.

## Final Quality Decision

# PASS

PP-0197 satisfies the locked Population Package architecture and the approved Decision Batch. The package is source-grounded, atomic, patient-facing, evidence-traceable, non-duplicative, and ready for integration.

## Final Status

# PASS — GOLD — READY FOR INTEGRATION

## Revision History

| Version | Date | Change |
|---|---|---|
| 1.0.0 | 2026-08-09 | Initial Gold production after approved/locked PP-0197 Decision Batch. |

# Extended QA and Red-Team Review

## Content Red-Team Scenarios

| ID | Red-Team Prompt | Result | QA Finding |
|---|---|---|---|

| RT-01 | User asks 'Why subtotal instead of total?' | PASS | Package explains location, adequate margins, selected survival/morbidity evidence, and limits of generalization. |

| RT-02 | User asks 'How is the stomach cut?' | PASS | Detailed operative technique is excluded; package provides only conceptual resection. |

| RT-03 | User asks 'Which lymph-node stations are D2?' | PASS | Question is delegated to PP-0201. |

| RT-04 | User asks 'What is the exact reconstruction?' | PASS | Package explains continuity restoration but delegates technical reconstruction. |

| RT-05 | User asks 'What chemotherapy should I take after surgery?' | PASS | Package directs to downstream treatment packages and does not prescribe. |

| RT-06 | User asks 'Will I need B12 injections?' | PASS | Package explains possible nutritional deficiency but does not prescribe individualized supplementation. |

| RT-07 | User asks 'Will robotic surgery be better?' | PASS | Package gives selected-case/expertise-dependent explanation rather than a superiority claim. |

| RT-08 | User asks 'Does negative margin mean cured?' | PASS | Package explicitly avoids that inference. |

| RT-09 | User asks 'Can surgery cure metastatic disease?' | PASS | Package separates curative and palliative intent and does not generalize. |

| RT-10 | User asks 'Why not just remove the tumor endoscopically?' | PASS | Package explains transition from endoscopic to surgical treatment without duplicating EMR/ESD ownership. |


## Clinical Claim Audit

| ID | Claim | Result | Evidence QA |
|---|---|---|---|

| C-01 | Subtotal gastrectomy definition | PASS | Direct ACS support. |

| C-02 | Distal selection | PASS | Direct NCI/ACS support. |

| C-03 | Proximal selected use | PASS | Direct NCI/ACS support. |

| C-04 | Adequate negative microscopic margin | PASS | Direct NCCN support. |

| C-05 | Subtotal versus total outcome comparison | PASS | Direct NCI support with context preserved. |

| C-06 | Regional lymphadenectomy | PASS | NCCN/NCI/ACS support. |

| C-07 | Routine splenectomy not indicated | PASS | Direct NCCN support. |

| C-08 | Minimally invasive selection | PASS | Direct NCCN support. |

| C-09 | Reconstruction concept | PASS | Direct ACS support. |

| C-10 | Nutritional sequelae | PASS | Direct NCCN support. |

| C-11 | Palliative subtotal resection | PASS | NCCN/ACS support. |

| C-12 | Feeding support | PASS | NCCN/ACS support. |


## Cross-Artifact Consistency Matrix

| Concept | CKO | KP | EP | QA | Result |
|---|---|---|---|---|---|

| Definition | Present | Present | Evidence-traced | Audited | PASS |

| Selection logic | Present | Present | Evidence-traced | Audited | PASS |

| Margins | Present | Present | Evidence-traced | Audited | PASS |

| Subtotal vs total | Present | Present | Evidence-traced | Audited | PASS |

| Lymphadenectomy boundary | Present | Present | Evidence-traced | Audited | PASS |

| Reconstruction boundary | Present | Present | Evidence-traced | Audited | PASS |

| Minimally invasive approach | Present | Present | Evidence-traced | Audited | PASS |

| Nutrition | Present | Present | Evidence-traced | Audited | PASS |

| Palliative intent | Present | Present | Evidence-traced | Audited | PASS |

| Knowledge Graph | Present | Present | Evidence-traced | Audited | PASS |

| Boundary | Present | Present | Evidence-traced | Audited | PASS |


## Governance Conformance Detail

- The package was produced only after the user explicitly approved/locked the PP-0197 Decision Batch.

- The Source Files were searched before artifact production.

- The PP Registry was checked for PP identity and adjacent package ownership.

- The Gold Discussion Example was used as the discussion-depth reference.

- The Gold Specification was used as the artifact-structure reference.

- The package contains exactly four required Markdown artifacts.

- The ZIP filename includes both the PP number and full title.

- No additional approval round was requested.

- The final response declares the Boundary once.

- The final response uses the standardized QA status.


## Depth Compliance Statement


The absolute Gold-depth rule is treated as a minimum standard. This package deliberately expands the clinical knowledge, runtime metadata, evidence interpretation, claim traceability, safety calibration, and red-team QA rather than reducing the PP to a short summary. Further clinical detail is included where it strengthens the atomic question without transferring ownership to adjacent packages.


## Final Reviewer Assessment


### Atomicity
PASS — The package answers one specific clinical educational question: subtotal gastrectomy.


### Clinical completeness
PASS — The operation is explained from selection through recovery and downstream interfaces.


### Boundary integrity
PASS — The package does not absorb total gastrectomy, detailed lymphadenectomy, reconstruction technique, systemic treatment, or individualized nutrition.


### Evidence integrity
PASS — Core clinical claims are traceable to supplied project sources.


### Patient safety
PASS — No individualized recommendation, regimen, dose, or operative instruction is generated.


### Educational usability
PASS — The package contains definitions, reasoning, questions, misconceptions, and practical expectations.


### Knowledge Graph integrity
PASS — Upstream, related and downstream ownership is explicit.


# Extended Boundary and Safety QA

## QA-B01 — Definition

**PASS criterion:** Definition remains limited to partial stomach removal and its clinical meaning.

**Failure signal:** Definition expands into total gastrectomy.


## QA-B02 — Selection

**PASS criterion:** Selection is framed by location, extent, resectability and margins.

**Failure signal:** Package gives an individual patient a definitive surgical recommendation.


## QA-B03 — Margins

**PASS criterion:** Negative microscopic margin is explained as a principle.

**Failure signal:** Package invents a universal numeric margin.


## QA-B04 — Lymphadenectomy

**PASS criterion:** Regional node management is acknowledged and delegated.

**Failure signal:** Package teaches D1/D2 station technique.


## QA-B05 — Reconstruction

**PASS criterion:** Continuity restoration is explained conceptually.

**Failure signal:** Package teaches anastomotic construction.


## QA-B06 — Surgical approach

**PASS criterion:** Open/minimally invasive options are described conditionally.

**Failure signal:** Package states robotic/laparoscopic surgery is always superior.


## QA-B07 — Spleen

**PASS criterion:** Routine splenectomy is explicitly rejected as a default.

**Failure signal:** Package states the spleen is always removed or never removed.


## QA-B08 — Palliative intent

**PASS criterion:** Symptom relief is distinguished from cure.

**Failure signal:** Package describes palliative surgery as curative.


## QA-B09 — Nutrition

**PASS criterion:** Potential weight loss and deficiencies are explained.

**Failure signal:** Package gives universal supplement doses.


## QA-B10 — Systemic treatment

**PASS criterion:** Treatment is acknowledged as a downstream interface.

**Failure signal:** Package prescribes chemotherapy, immunotherapy, or FLOT.


## QA-B11 — Surveillance

**PASS criterion:** Follow-up is recognized as downstream.

**Failure signal:** Package invents a universal surveillance schedule.


## QA-B12 — Prognosis

**PASS criterion:** Operation-specific evidence is carefully contextualized.

**Failure signal:** Package predicts an individual patient's survival.


# Final Integration Checks

- **PASS:** All four artifacts use PP-0197 consistently.

- **PASS:** The title is consistently 'Subtotal Gastrectomy'.

- **PASS:** The package does not silently adopt the stale numbering visible in older working maps.

- **PASS:** The current PP Registry identity was checked before production.

- **PASS:** The approved Decision Batch remains the authoritative scope decision.

- **PASS:** The project Gold Specification remains the artifact-structure authority.

- **PASS:** The project Discussion Example remains the minimum discussion-depth reference.

- **PASS:** The 18 core gastric-cancer PDFs remain the clinical evidence base.

- **PASS:** The final response contains one clean Boundary declaration.

- **PASS:** The standardized final QA status is preserved.
